Research areas
Dr Muge Cevik is a clinical lecturer in infectious diseases and medical virology. Her research interests focus on HIV, tuberculosis, other tropical infections and emerging infections including Covid-19 since the beginning of 2020.
During the Covid-19 pandemic, as well as working on the NHS front line of the response, Dr Cevik provided scientific advice to the Chief Medical Officer – Scotland and advisory groups on recent scientific developments on Covid-19. She has been co-opted to NERVTAG (New and Emerging Respiratory Virus Threats Advisory Group) as a member for Covid-19, advising and producing guidance documents for UK-SAGE (Scientific Advisory Group for Emergencies). She also provided advice and consultancy to the World Health Organisation (WHO) on risk communication during Covid-19 pandemic.
Dr Cevik is also coordinating the recruitment of hospitalised COVID-19 patients in South East Asia and South Africa working closely with the International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC) funded by the Wellcome Trust. Additionally, she is co-leading a household transmission study in Scotland as well as a prospective study to quantify the burden of Covid-19 in patients with tuberculosis in Kampala, Uganda, with support from GCRF-NIHR. She is part of the CORRE Network (Covid-19 International Rapid Evidence Reviews Group) working towards providing rapid reviews for governments and the WHO.
Alongside her academic work, Dr Cevik developed a strong interest in science communication. She is passionate about the value of integrating science communication into our efforts to disseminate research, which has the potential to enhance knowledge exchange among scientists and physicians, and the broader public.
Selected publications
-
Open access
A population framework for predicting the proportion of people infected by the far-field airborne transmission of SARS-CoV-2 indoors
Iddon, C., Jones, B., Sharpe, P., Cevik, M. & Fitzgerald, S., 1 Aug 2022, In: Building and Environment. 221, 12 p., 109309.Research output: Contribution to journal › Article › peer-review
-
Association between women's authorship and women's editorship in infectious diseases journals: a cross-sectional study
Last, K., Hübsch, L., Cevik, M., Wolkewitz, M., Müller, S. E., Huttner, A. & Papan, C., 12 Jul 2022, (E-pub ahead of print) In: Lancet Infectious Diseases. In pressResearch output: Contribution to journal › Article › peer-review
-
Open access
Indirect protection by reducing transmission: ending the pandemic with SARS-CoV-2 vaccination
Richterman, A., Meyerowitz, E. A. & Cevik, M., 20 Feb 2022, In: Open Forum Infectious Diseases. 9, 2, 6 p., ofab259.Research output: Contribution to journal › Article › peer-review
-
Open access
Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: update of a living systematic review and meta-analysis
Buitrago-Garcia, D., Ipekci, A. M., Heron, L., Imeri, H., Araujo-Chaveron, L., Arevalo-Rodriguez, I., Ciapponi, A., Cevik, M., Hauser, A., Alam, M. I., Meili, K., Meyerowitz, E. A., Prajapati, N., Qiu, X., Richterman, A., Robles-Rodriguez, W. G., UK, U. O. M., Zhelyazkov, I., Salanti, G. & Low, N., 26 May 2022, In: PLoS Medicine. 19, 5, 30 p., e1003987.Research output: Contribution to journal › Article › peer-review
-
Role and perception of clinical microbiology and infectious diseases trainees during the COVID-19 crisis
Bouiller, K., Peiffer-Smadja, N., Cevik, M., Last, K., Antunović, I. A., Šterbenc, A., Lopes, M. J., Barac, A., Schweitzer, V. & Dellière, S., Apr 2022, In: Future Microbiology. 17, 6, p. 411-416 6 p.Research output: Contribution to journal › Article › peer-review
-
Open access
A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB
Tweed, C. D., Wills, G. H., Crook, A. M., Amukoye, E., Balanag, V., Ban, A. Y. L., Bateson, A. L. C., Betteridge, M. C., Brumskine, W., Caoili, J., Chaisson, R. E., Cevik, M., Conradie, F., Dawson, R., del Parigi, A., Diacon, A., Everitt, D. E., Fabiane, S. M., Hunt, R., Ismail, A. I., Lalloo, U., Lombard, L., Louw, C., Malahleha, M., McHugh, T. D., Mendel, C. M., Mhimbira, F., Moodliar, R. N., Nduba, V., Nunn, A. J., Sabi, I., Sebe, M. A., Selepe, R. A. P., Staples, S., Swindells, S., van Niekerk, C. H., Variava, E., Spigelman, M. & Gillespie, S. H., 1 Apr 2021, In: International Journal of Tuberculosis and Lung Disease. 25, 4, p. 305-314 10 p.Research output: Contribution to journal › Article › peer-review
-
Open access
Aims and challenges of building national trainee networks in clinical microbiology and infectious disease disciplines
Dellière, S., Peiffer-Smadja, N., João-Lopes, M., Cevik, M., Pichon, M., Bleibtreu, A., Schweitzer, V., Last, K., Ferreira, T. G., Lemaignen, A. & Barac, A., Jul 2021, In: Future Microbiology. Epub ahead of print, 9 p., fmb-2021-0045.Research output: Contribution to journal › Article › peer-review
-
COVID-19 vaccines: keeping pace with SARS-CoV-2 variants
Cevik, M., Grubaugh, N. D., Iwasaki, A. & Openshaw, P., 16 Sep 2021, In: Cell.Research output: Contribution to journal › Comment/debate
-
COVID-19, children and schools: overlooked and at risk
Munro, A., Bowen, A. C. & Cevik, M., 28 Feb 2021, In: Medical Journal of Australia. 214, 4, p. 188-188.e1Research output: Contribution to journal › Comment/debate
-
Covid-19 vaccination: evidence of waning immunity is overstated
Scott, J., Richterman, A. & Cevik, M., 23 Sep 2021, (E-pub ahead of print) In: BMJ. 374, 2 p., n2320.Research output: Contribution to journal › Editorial